In Depth Focus: Outsourcing
Drug Discovery World
Disruptive change by linked data and semantic technologies in healthcare and life sciences
By Hans Constandt
Fall 2013

From early days the sharing of knowledge has been one of the main forces driving science and innovation. Yet latterly, the pharmaceutical industry with its fear of loss of intellectual property has stalled the engine that has given so many beneficial outcomes.

The pharmaceutical industry is undergoing an enormous shift in structure and strategy to reinvent how to bring new drugs to market efficiently.

Global drug development strategies are changing from the ‘we can do all’ to functional outsourcing relationships, academic alliances, building innovation networks with multiple players, consolidation and partnerships, expansion into emerging markets, use of public private partnerships (PPP), orphan drugs and translational science. All reflect new thinking aimed at achieving higher R&D efficiency and greater return ..........